Clinical trial
A Randomized Study of Chemotherapy Versus Hormonal Treatment in Patients With Ovarian Cancer Resistant or Refractory to Platinum and Taxane
NCT02728622 is registered in ClinicalTrials.gov with Nordic Society of Gynaecological Oncology - Clinical Trials Unit as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Study of Chemotherapy Versus Hormonal Treatment in Patients With Ovarian Cancer Resistant or Refractory to Platinum and Taxane
- Lead sponsor
- Nordic Society of Gynaecological Oncology - Clinical Trials Unit
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2002
- Completion date
- January 31, 2009
- Enrollment
- 241 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of the fallopian tube, ovarian cancer, peritoneal cancer